Clinical Trial Update: Berberine as Adjuvant Treatment for Schizophrenia Patients [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial investigating berberine as an adjuvant treatment for schizophrenia and related psychotic disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Schizophrenia Spectrum and Other Psychotic Disorders

Drugs mentioned

• Berberine (berberine)

Snippet

Sponsor: The University of Hong Kong | Conditions: Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders | Phase 2, Phase 3 | Status: COMPLETED